Navigation Links
Major advances in breast, prostate, colorectal cancer featured at ASCO Annual Meeting
Date:6/2/2014

CHICAGO Findings from four phase III clinical trials in breast, prostate, and colorectal cancers were released today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO). The studies were presented in ASCO's Plenary session, which features the meeting's most important clinical cancer research with the greatest potential to impact patient care.

These pivotal studies reveal new ways to optimize commonly used chemotherapy, hormone therapies, and newer targeted drugs, and answer critical questions about the comparative effectiveness of two common treatment regimens for advanced colorectal cancer. All four trials were supported, at least in part, with federal funding through the U.S. National Institutes of Health.

"Today's results answer critical questions faced by people with cancer and their doctors every day. There is no doubt that patients will live longer and better because of these studies," said Clifford A. Hudis, MD, FACP, president of ASCO and chief of the Breast Cancer Medicine Service at Memorial Sloan-Kettering Cancer Center. "These major advances and many others in the history of cancer research were only possible thanks to our nation's long-standing commitment to funding clinical cancer research. That commitment must be sustained."

The Plenary studies are:

Adjuvant exemestane is more effective than tamoxifen when combined with ovarian function suppression in young women with hormone-sensitive, early-stage breast cancer: Post-surgery (adjuvant) exemestane is more effective at preventing breast cancer recurrences than tamoxifen when given with ovarian function suppression in young women with hormone receptor-positive, early breast cancer, reducing the relative risk of developing a recurrent cancer by 28 percent.

Addition of docetaxel to initial hormone therapy substantially improves survival in men with metastatic, hormone-sensitive prostate cancer: The findings sugges
'/>"/>

Contact: Wendy Stokes
wendy.stokes@asco.org
312-949-3232
American Society of Clinical Oncology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Researchers address major geographic disparities in access to kidney transplantation
2. Major discovery on the mechanism of drug resistance in leukemia and other cancers
3. Major EPSRC Programme Grant to support new Oxford Centre for Drug Delivery Devices
4. Therapy sought to reduce major risk from minor bleeding that can follow stroke
5. Major lung resection safer than ever, especially at the busiest hospitals
6. Genetic alterations in shared biological pathways as major risk factor for ASD
7. Gen X obesity a major problem for healthcare, workforce
8. Surgery after major stroke also improves survival odds in elderly patients
9. A majority prefers letting computers decide
10. Major third-hand smoke compound causes DNA damage -- and potentially cancer
11. Patient requests for specific drugs have major impact on prescribing, reports study in Medical Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... 30, 2014 August 28th, 2014: ... in our society and the toll that takes on ... vital that continuing education for physical therapists addresses this ... physical therapists help others, Hands-On Seminars is offering discounts ... , Three learning styles are available to fit the ...
(Date:8/30/2014)... When a prominent bank reveals a successful cyber attack, ... 27th, when news began surfacing about the FBI probing ... and at least one other bank. But when news gets ... seven prominent banks , everyone starts thinking about their own ... quickly goes viral. Bloomberg followed up on Friday with ...
(Date:8/30/2014)... Columbus, Ohio (PRWEB) August 30, 2014 As ... serioius birth defect when give to pregnant mothers, Wright & ... District Judge Cynthia M. Rufe. The remand in ... are representative of 18 states and are involved in one ... allows them to have their Zoloft birth defect lawsuit sent ...
(Date:8/30/2014)... Barton Associates, an industry leading physician, ... , announces a new office location in Keene, NH, ... headquartered in Peabody, MA, with additional staffing centers in ... Jupiter, FL. , Barton Associates made the decision to ... crisis affecting the United States, a crisis that will ...
(Date:8/30/2014)... Saturday 30 August 2014: The first multidisciplinary recommendations ... acute coronary syndromes (ACS) are published today in ... was written jointly by the European Heart Rhythm ... and the European Association of Percutaneous Cardiovascular Interventions ... Bulent Gorenek (Turkey), chairperson of the task force, ...
Breaking Medicine News(10 mins):Health News:Leader in Manual Therapy Continuing Education Makes it Easier for Physical Therapists to Improve Results on Patients 2Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 2Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 3Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 4Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 5Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 2Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 3Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 4Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 5Health News:Barton Associates to Open a New Office Location in Keene, NH 2Health News:First multidisciplinary recommendations on management of arrhythmias in ACS patients 2
... 10 The Council for American Medical Innovation today ... Collins to head the National Institutes of Health (NIH). ... ) , , "Dr. Collins is ... pioneer in medical innovation," said Council President Dick Gephardt. ...
... July 10 Americans United for Life (AUL) announced today ... called to testify at the confirmation hearings for Judge Sonia ... AUL President Charmaine Yoest said "We are honored to have ... nomination of Judge Sotomayor to the highest court in the ...
... Germany, July 10 The supervisory board of Celesio ... per cent in pharmaceutical wholesaler Panpharma. This step into ... world-wide is part of Celesio,s growth strategy. Celesio doesn,t ... , Celesio spent about two years thoroughly analysing ...
... Healthy reaction to mental stress not seen in those with ... News) -- Anger and other forms of mental stress cause ... blood to the brain in healthy people, but this doesn,t ... finding of U.S. researchers who used ultrasound imaging to monitor ...
... months of protests, media coverage and online uproar, Oscar ... mental health organization, and Kipp Berdiansky, co-owner of the ... to discuss mental illness, the associated stigma and the ... Berdiansky and Jordan Zweigoron opened Psycho Donuts in March ...
... Aegis of Granada Hills has been named "Best Assisted Living Facility" ... annual Readers Choice Awards. This is the second year in a ... In voting, Aegis was a write-in candidate and received more ... area to gain top status. , , "We ...
Cached Medicine News:Health News:Council for American Medical Innovation Applauds Appointment of Geneticist Francis Collins to Head National Institutes of Health 2Health News:Americans United for Life President to Testify at Sotomayor Senate Judiciary Hearing 2Health News:Celesio Acquires Majority Stake in Number One Brazilian Pharmaceutical Wholesaler Panpharma 2Health News:Blood Rush to the Brain When Angry Is a Good Sign 2Health News:There Is No Way to Sugar Coat These Donuts 2
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely ... a generation ago are returning. Measles was declared eliminated ... in 2014 as of August 15—the highest incidence in ... public health department declared whooping cough a problem of ... are getting sick and dying from these preventable diseases—in ...
(Date:8/29/2014)... DUBLIN , Aug. 29, 2014 ... the "Global Multiple Sclerosis Drugs Market 2014-2018" ... is a chronic, inflammatory medical condition that results in ... damaged because of an abnormal response by the immune ... (CNS). It is a potentially debilitating disease in which ...
(Date:8/29/2014)... Calif. , Aug. 29, 2014  Pacific Medical ... its new website design . The main website, ... that showcases the company,s new services and content relevant ... implementing a new streamlined design, viewers can now better ... for health care practices and create a more visible ...
Breaking Medicine Technology:Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3PMDS Announces New Website 2
... Research and Manufacturers of America (PhRMA) today announced the ... Directors. "We are pleased to welcome four ... said PhRMA President and Chief Executive Officer John J. ... sectors in the U.S., they bring to the table ...
... Dec. 21, 2010 Reportlinker.com announces that a ... catalogue: Thai Self-monitoring of Blood ... http://www.reportlinker.com/p0350305/Thai-Self-monitoring-of-Blood-Glucose-SMBG-Devices-and-Strips-Market.html This Market ... the dynamics of blood glucose monitoring device sales ...
Cached Medicine Technology:PhRMA Elects Four New Members to Board of Directors 2PhRMA Elects Four New Members to Board of Directors 3
... contains primers and a FAM-labeled probe that ... gene. In addition, this ASR contains primers, ... internal control sequence. This ASR requires an ... Red reporter dyes such as the Cepheid ...
...
Reptilase-Time from Bothrops atrox...
Thrombin Activatable Fibrinolysis Inhibitor Assay Kit...
Medicine Products: